Conditions could be ripe for the first $20 billion-plus biopharma deal in more than three years, according to Centerview Partners Co-President Eric Tokat. Tokat and Paul Weiss's Krishna Veeraraghavan joined Dani Burger and Michelle F. Davis on “Bloomberg Deals” for a roundtable to discuss their outlooks for biopharma M&A.
Момент удара ракеты по спутниковой станции в Израиле попал на видео20:56
。关于这个话题，吃瓜提供了深入分析
02“顶流”下乡，但流量上浮既然主品牌的“大店模式”无法全盘复制，蜜雪想要维持增长神话，就只能靠子品牌去冲锋陷阵，而蜜雪选择了“咖啡”和“鲜啤”的赛道。
Дан прогноз по ключевой ставке в России14:48
17:32, 13 марта 2026Экономика